Catalog No.
YVV20304
Expression system
E. coli
Species
Enterovirus A (GZ2010-156)
Protein length
Gly566-Leu862
Predicted molecular weight
60.26 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
F5AU45
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Genome polyprotein, Capsid protein VP1, P1D, Virion protein 1
Enterovirus 71 structural viral protein 1 promotes the expression of PMP22 through m6A modification in mouse Schwann cells., PMID:40480313
MiR-362-3p mediates IFNα-induced antiviral viability against Enterovirus 71 (EV71)., PMID:40137969
ZYG11B suppresses multiple enteroviruses by triggering viral VP1 degradation., PMID:40135890
6-thioguanine inhibits EV71 replication by reducing BIRC3-mediated autophagy., PMID:39881250
Metabolomics combined with network pharmacology reveals a role for astragaloside IV in inhibiting enterovirus 71 replication via PI3K-AKT signaling., PMID:38858642
NSUN2 mediates distinct pathways to regulate enterovirus 71 replication., PMID:38768712
Immunogenicity and immunodominant linear B-cell epitopes of a new DNA-based tetravalent vaccine against four major enteroviruses causing hand, foot, and mouth disease., PMID:38705805
Foot-and-mouth disease virus VP1 degrades YTHDF2 through autophagy to regulate IRF3 activity for viral replication., PMID:38516932
Isolation and identification of active components from Grifola frondosa and its anti-EV71 virus effect., PMID:38323723
High mobility group box 1 knockdown inhibits EV71 replication and attenuates cell pyroptosis through TLR4/NF-κB/NLRP3 axis., PMID:38229319
Anti-α-glucosidase, Anti-proliferative and Anti-enterovirus 71 Activity of Secondary Metabolites Identified from Grifola Frondosa., PMID:37812276
Targeting HNRNPA2B1 inhibits enterovirus 71 replication in SK-N-SH cells., PMID:37716669
miR-342-5p targets CTNNBIP1 to promote enterovirus 71 replication., PMID:37479047
Cell membrane-bound toll-like receptor-1/2/4/6 monomers and -2 heterodimer inhibit enterovirus 71 replication by activating the antiviral innate response., PMID:37207203
Human SCARB2 Acts as a Cellular Associator for Helping Coxsackieviruses A10 Infection., PMID:37112912
Variant enterovirus A71 found in immune-suppressed patient binds to heparan sulfate and exhibits neurotropism in B-cell-depleted mice., PMID:37058406
Inhibitory effects and mechanisms of proanthocyanidins against enterovirus 71 infection., PMID:36944412
The upregulation of peripheral blood polyamine metabolites spermidine and spermine in children with hand, foot, mouth disease is related to enterovirus 71 capsid protein VP1, but not VP4., PMID:36891375
Intranasal immunization with curdlan induce Th17 responses and enhance protection against enterovirus 71., PMID:36863926
Insertion of an Amphipathic Linker in a Tetrapodal Tryptophan Derivative Leads to a Novel and Highly Potent Entry Inhibitor of Enterovirus A71 Clinical Isolates., PMID:36834952
Enterovirus 71 VP1 promotes 5-HT release by upregulating the expression of ERICH3 and methyltransferase ZC3H13., PMID:35660571
Fucosylated oligosaccharide Lacto-N-fucopentaose I ameliorates enterovirus 71 infection by inhibiting apoptosis., PMID:35499022
Human Norovirus Induces Aquaporin 1 Production by Activating NF-κB Signaling Pathway., PMID:35458572
[Preparation of monoclonal antibody against enterovirus 71 capsid protein VP1]., PMID:35365993
Recovery Infectious Enterovirus 71 by Bac-to-Bac Expression System in vitro and in vivo., PMID:35356523
[Effect of Pien Tze Huang against EV71]., PMID:35343163
Heat Shock Protein A6 Is Especially Involved in Enterovirus 71 Infection., PMID:35308396
Does enterovirus 71 urge for effective vaccine control strategies? Challenges and current opinion., PMID:34997684
Inhibition of enterovirus 71 infection by polysaccharides extracted from Picochlorum sp. 122 via the AKT and ATM/ATR signaling pathways., PMID:34536128
[Preparation of pan-neutralizing mouse monoclonal antibodies against enterovirus 71 and coxsackievirus A16]., PMID:34140076
Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection., PMID:34116877
Sporadic hand, foot, and mouth disease cases associated with non-C4 enterovirus 71 strains in Xiamen, China, from 2009 to 2018., PMID:34008106
Genetic analysis of Enterovirus D68 associated with pneumonia in children from South India., PMID:33999799
The Upregulation of a Novel Long Noncoding RNA AK097647 Promotes Enterovirus 71 Replication and Decreases IFN-λ1 Secretion., PMID:33951637
SAMHD1 Inhibits Multiple Enteroviruses by Interfering with the Interaction between VP1 and VP2 Proteins., PMID:33883225
MiR-103/miR-107 inhibits enterovirus 71 replication and facilitates type I interferon response by regulating SOCS3/STAT3 pathway., PMID:33796959
Cathelicidin antimicrobial peptides suppress EV71 infection via regulating antiviral response and inhibiting viral binding., PMID:33508330
Transplantation of Enterovirus 71 Virion Protein Particle Vaccine Protects Against Enterovirus 71 Infection in a Neonatal Mouse Model., PMID:33397838
Recombinant Enterovirus 71 Viral Protein 1 Fused to a Truncated Newcastle Disease Virus NP (NPt) Carrier Protein., PMID:33297428
Human Antibodies to VP4 Inhibit Replication of Enteroviruses Across Subgenotypes and Serotypes, and Enhance Host Innate Immunity., PMID:33101238
Ginsenoside Rb1 is an immune-stimulatory agent with antiviral activity against enterovirus 71., PMID:32980486
Rational Design of a Replication-Competent and Inheritable Magnetic Viruses for Targeting Biomedical Applications., PMID:32954651
A Single Mutation in the VP1 Gene of Enterovirus 71 Enhances Viral Binding to Heparan Sulfate and Impairs Viral Pathogenicity in Mice., PMID:32823486
Molecular characteristics of the VP1 region of enterovirus 71 strains in China., PMID:32818043
Virological investigation of genetic variation of enterovirus type 71 in hand, foot and mouth disease., PMID:32537012
Epitope Peptide Amphiphile-Based Nanofiber as an Effective Vaccine for Viral Infectious Diseases., PMID:32331099
Heparan sulfate attachment receptor is a major selection factor for attenuated enterovirus 71 mutants during cell culture adaptation., PMID:32187235
Coxsackievirus A6 Induces Necroptosis for Viral Production., PMID:32117097
Metabolic Reprogramming of Host Cells in Response to Enteroviral Infection., PMID:32085644
VP1-binding protein glucose-regulated protein 78 as an important mediator for enterovirus 71 infecting human brain microvascular endothelial cells., PMID:32003341
For research use only. Not for human or drug use.
